We are live on ! Find out more
RCM

Raleigh Capital Management Portfolio holdings

AUM $313M
1-Year Est. Return 23.55%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+23.55%
3 Year Est. Return
+71.82%
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
+$21.2M
Cap. Flow
+$5.43M
Cap. Flow %
2.82%
Top 10 Hldgs %
19.8%
Holding
915
New
76
Increased
369
Reduced
163
Closed
149

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.01M
2
CVX icon
Chevron
CVX
+$861K
3
XOM icon
ExxonMobil
XOM
+$817K
4
BMY icon
Bristol-Myers Squibb
BMY
+$696K
5
MRK icon
Merck
MRK
+$685K

Sector Composition

Rank Sector Weight
1 Financials 10.54%
2 Healthcare 10.29%
3 Consumer Staples 9.47%
4 Energy 7.21%
5 Utilities 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$876B
$6.63M 3.45%
17,252
-524
-3% -$202K
FISR icon
2
State Street Fixed Income Sector Rotation ETF
FISR
$484M
$4.42M 2.3%
172,784
-8,813
-5% -$226K
GILD icon
3
Gilead Sciences
GILD
$161B
$3.99M 2.08%
46,497
-3,924
-8% -$311K
PM icon
4
Philip Morris
PM
$301B
$3.77M 1.96%
37,290
+2,526
+7% +$238K
VZ icon
5
Verizon
VZ
$194B
$3.57M 1.86%
90,612
+9,932
+12% +$374K
ESGU icon
6
iShares ESG Aware MSCI USA ETF
ESGU
$17.6B
$3.3M 1.72%
38,990
-6,234
-14% -$532K
BTI icon
7
British American Tobacco
BTI
$132B
$3.22M 1.67%
80,463
+6,681
+9% +$263K
TTE icon
8
TotalEnergies
TTE
$193B
$3.09M 1.61%
49,735
+3,520
+8% +$201K
SPAB icon
9
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
$3.08M 1.6%
122,641
+34,900
+40% +$874K
ABBV icon
10
AbbVie
ABBV
$458B
$2.99M 1.56%
18,503
+821
+5% +$126K
DUK icon
11
Duke Energy
DUK
$102B
$2.9M 1.51%
28,184
+5,714
+25% +$549K
SO icon
12
Southern Company
SO
$110B
$2.84M 1.48%
39,824
+3,766
+10% +$252K
BIL icon
13
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
$2.75M 1.43%
30,119
-468
-2% -$42.8K
CCI icon
14
Crown Castle
CCI
$32.7B
$2.65M 1.38%
20,468
+6,395
+45% +$865K
T icon
15
AT&T
T
$165B
$2.65M 1.38%
143,996
+10,648
+8% +$191K
PFE icon
16
Pfizer
PFE
$140B
$2.59M 1.35%
50,540
+8,539
+20% +$409K
ENB icon
17
Enbridge
ENB
$124B
$2.59M 1.35%
66,150
+5,929
+10% +$232K
JPM icon
18
JPMorgan Chase
JPM
$939B
$2.58M 1.34%
19,256
+4,074
+27% +$516K
MRK icon
19
Merck
MRK
$324B
$2.42M 1.26%
21,821
-6,698
-23% -$685K
XLSR icon
20
State Street US Sector Rotation ETF
XLSR
$996M
$2.42M 1.26%
62,214
+7,311
+13% +$284K
SPDW icon
21
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.7B
$2.41M 1.26%
81,333
+4,229
+5% +$121K
BCE icon
22
BCE
BCE
$19.9B
$2.37M 1.23%
54,017
+10,279
+24% +$463K
GLD icon
23
SPDR Gold Trust
GLD
$131B
$2.28M 1.19%
13,464
-1,690
-11% -$272K
WMB icon
24
Williams Companies
WMB
$90.5B
$2.27M 1.18%
69,048
+6,476
+10% +$211K
CSCO icon
25
Cisco
CSCO
$450B
$2.26M 1.17%
47,414
+1,563
+3% +$71.1K

Similar funds

Raleigh Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Raleigh Capital Management held 915 positions worth $192M, up 12% from $171M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raleigh Capital Management's Q4 2022 filing shows 76 new, 369 increased, 163 reduced and 149 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M. The largest sale was Amgen, an estimated $1.01M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Raleigh Capital Management's largest Q4 2022 buy was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M.
  • Raleigh Capital Management added most to Medtronic in Q4 2022, an estimated $1.02M increase.
  • Raleigh Capital Management's biggest Q4 2022 reduction was Amgen, cutting an estimated $1.01M.
  • Raleigh Capital Management fully exited iShares Core High Dividend ETF in Q4 2022, selling an estimated $454K.
  • Raleigh Capital Management's ten largest holdings make up 20% of its $192M portfolio in Q4 2022.
  • Raleigh Capital Management opened 76 new positions and closed 149 in Q4 2022.
  • Raleigh Capital Management's portfolio value rose 12% quarter-over-quarter to $192M.

Based on Raleigh Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.